I-N-Acetyl-L-cysteine CAS:616-91-1
I-Antioxidant: I-NAC isebenza njenge-antioxidant ngokugcwalisa amazinga e-glutathione emzimbeni. I-Glutathione iyi-antioxidant enamandla esiza ukuvikela amaseli ekulimaleni kwe-oxidative okubangelwa ama-free radicals.
I-Mucolytic: I-NAC inezakhiwo ze-mucolytic, okusho ukuthi iyasiza ekuqhekekeni nasekunciphiseni i-mucus ohlelweni lokuphefumula. Lokhu kuyenza ibe usizo ezimweni lapho ukwakheka kwe-mucus kuyinkinga, njenge-bronchitis engapheli, i-COPD, kanye ne-cystic fibrosis.
Ukusekelwa kwesibindi: I-NAC ingasekela impilo yesibindi kanye nezinqubo zokukhipha ubuthi ngokusiza ekususweni kobuthi, okuhlanganisa i-acetaminophen (umuthi ovamile wokuqeda ubuhlungu) kanye nokungcola kwemvelo. Kungaba nomthelela wokuvikela ekulimaleni kwesibindi okubangelwa ukuphuza utshwala.
Impilo yengqondo: I-NAC iye yacwaningwa ngezinzuzo zayo ezingaba khona ezimweni ezithile zempilo yengqondo. Ingaba nomthelela omuhle ezinkingeni zemizwa, njengokucindezeleka kanye nesifo sokuzikhukhumeza (OCD). Kucatshangwa ukuthi isebenza ngokushintsha amazinga ama-neurotransmitter afana ne-glutamate, adlala indima ekulawuleni imizwa.
Izimo zokuphefumula: Ngenxa yezakhiwo zayo zokubulala amagciwane, i-NAC ivame ukusetshenziswa njengesithako sokukhipha uketshezi esiza ukukhulula nokuhlanza ulwelwesi emigwaqweni yomoya. Lokhu kungaba usizo kubantu abanezimo ezifana ne-bronchitis, i-COPD, kanye ne-cystic fibrosis.
Ukwelashwa ngokweqile kwe-Acetaminophen: I-NAC iyindlela yokwelapha ekhethwayo yokudlula ngokweqile kwe-acetaminophen. Isiza ukuvimbela ukulimala kwesibindi ngokwandisa amazinga e-glutathione kanye nokulwa nemiphumela enobuthi yomuthi.
| Ukwakheka | C5H9NO3S |
| Ukuhlolwa | 99% |
| Ukubukeka | Impuphu emhlophe |
| Inombolo ye-CAS | 616-91-1 |
| Ukupakisha | Encane futhi enkulu |
| Impilo Yeshelufu | iminyaka engu-2 |
| Isitoreji | Gcina endaweni epholile neyomile |
| Isitifiketi | I-ISO. |




![I-2-Methylpyrazolo[1,5-a]pyriI-Midine-6-carboxylic acidI-CAS:739364-95-5](https://cdn.globalso.com/xindaobiotech/2WI17RKBWR11PZUDNLH62.png)



